skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: Based on the release of restricted shares on Sept 5,what effect would you expect to both volume & share movement?
Thanks
Read Answer Asked by Robert on September 03, 2015
Q: After backing off from it's highs this stock has commenced moving up aagain on considerable volume. Any observations, updates given the recent move?
Read Answer Asked by Rick on September 02, 2015
Q: Can I get your thoughts on GUD's latest transaction?

https://research.tdwaterhouse.ca/research/public/Markets/NewsArticle/100-243u7771-1
Read Answer Asked by Arneh on September 02, 2015
Q: Read your comments today re: the 6/30 quarter for PHM. However, since these statements are only INTERNAL, I would appreciate your opinion as to their veracity since the erstwhile Principals leave me somewhat uneasy and skeptical. Thank you.
Read Answer Asked by Robert on September 01, 2015
Q: Peter et al.

Any thoughts on this one. It is the rebranded Bioniche. They recently got an FDA notification that their bladder cancer drug (Urocidin) will get FDA fast-track review. They seem well cashed up, but do have a lot of shares outstanding (280 million). Thanks.
Read Answer Asked by MARK on August 31, 2015
Q: What is your viewpoint on CRH Medical? Bought a half position this week at $4.80. I am looking at a 3 to 4 year hold on this one. I missed out on Concordia Healthcare as I would have liked to have bought it at $60 and it took off before I could. Could this be the next Concordia?

Regards,

Brendan
Read Answer Asked by Brendan on August 31, 2015
Q: Can you tell me when the shares come off restriction? Iknow it is Sept. but what day? Also, is there a reasonable limit on how many options the executives of a company should award themselves and the strike price? Thanks.
Read Answer Asked by wendy on August 28, 2015
Q: CPH continues to get punished, down even on big market up days. I'm tempted to take a (big) tax loss but would value your opinion on whether to hold on for a future recovery.
Read Answer Asked by richard on August 28, 2015
Q: Way down over last little while: good dividend, high ROE, ROI and trades at PE of 6, drug in long-term trial & if successful would mean a huge incr. in scripts, sold off some OTC products to another company. Comments please as I have been watching this one for a couple of years. I own J & J in my USD portfolio already & was thinking of adding this one?
Read Answer Asked by James on August 27, 2015
Q: For high risk, what is your view on Profound Medical? It has fallen hard with other small cap. Goodman from Knight is involved financially and at the board level. Other backers include the government. I'm not in a rush with this one and under $1 it looks interesting to me.
Read Answer Asked by James on August 27, 2015
Q: Hi Peter and Staff
The value of your service keeps shining through. At least if you sour on a stock we hear about it and if you soured enough on one in your portfolio you would drop it and we would hear about it. Jason Donville is a smart man but having added one of his Top Picks from October( Cipher) ,November (Direct Cash) and December (Biosyvent) and hearing on subsequent shows he dumped Cipher and Direct Cash since, it puts a pale note on following BNN Top Picks.....is RX a sell or hold at this time, I am under water on all 3 large.
Thanks for all you do
Read Answer Asked by Dennis on August 27, 2015
Q: Hi 5i team,

At this current time would you side with PLI or NHC as a buy? I currently have CRH, PHM, PLI and CXR all around half positions. I was thinking about selling PLI and increasing my positions in CRH and CXR as they seem to have better stock momentum.

Look forward to hearing your thoughts.

Thanks as always,

Jon
Read Answer Asked by Jonathan on August 26, 2015
Q: Hello team, What's your opinion on GUD? (has hold pretty well). I was looking at a big gap @ ~ 6.15....do you think it would get fill (if you believe in gaps always getting filled)? Do you think this correction is over?
Thank you!
Read Answer Asked by Silvia on August 25, 2015
Q: My understanding is that the courts recently ruled in favour of ENL against Allergan and upheld ENL's patents. I have equity in both companies. What I don't understand is why ENL is down more than 12.5% today and Allergan down only 2.5%. Is ENL a stock worth considering buying more of?
Read Answer Asked by Neil on August 25, 2015
Q: In response to a recent inquiry you indicated Casey Hoyt, one of two new principals at PHM, owns 1.5% of the shares. Canadian Insider shows both he and Michael Moore own 19 million shares each and Max Hoyt owns 4.7 million. Collectively, that totals just under fifteen percent. In addition, according to Bruce Campbell during his Wednesday BNN appearance, they paid $1.46 per share. If these numbers are correct, that certainly provides a huge incentive for the new guys.
Has PHM commenced their share buyback and would their listing application for the TSX be in jeopardy due to price erosion?
Thanks.
Read Answer Asked by Steven on August 21, 2015
Q: I own some CRH and would like your opinion on its current state.
It seems to be dropping a bit more than most. Any fundamental news or are investors just spooked for now? Would you consider it a good hold?
Read Answer Asked by Stephen on August 21, 2015
Looking for more? Sign up for a FREE 14 day trial! No credit card required

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!